FDA rejects Bayer's aspirin request in the US

12 May 2014 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has told Bayer HealthCare that there is currently insufficient data to support the use of aspirin for preventing a first heart attack or stroke.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: